Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
490 Leser
Artikel bewerten:
(2)

Aflac Incorporated: When an Ounce of Prevention Can Be Worth a Lifetime of Cure

NORTHAMPTON, MA / ACCESSWIRE / February 21, 2024 / Aflac Incorporated
Originally published on the Aflac Newsroom

By Dan Amos, Chairman, CEO, and President, Aflac Incorporated

A few years ago, a friend told me his wife had been feeling out of sorts. She didn't know why, but because of the pandemic she hadn't been going to her regularly scheduled checkups. When she finally went, the news wasn't good. Stage 3 cancer.

Dan Amos, Chairman, CEO, and President, Aflac Incorporated.

Thankfully, she continues to improve, but sadly, her story isn't unique. Research shows that millions of Americans neglected their personal health during the pandemic,1 and while too many still are, I am pleased that our claims volume continues to return to pre-pandemic levels. We want to pay claims, and here's why.

As an insurance company, managing risk is what we do. For policyholders, we see part of managing risk to mean that they will take more charge of their personal health care needs. That's because we know that preventive care, like routine checkups and prescribed screenings, helps save lives, and as stewards of our customers' health and financial security, we are obligated to encourage this behavior through our policy offerings and our words.

Proactive care ought to be important to everyone, as not only can an ounce of prevention be worth a lifetime of cure, in the long run, early detection can help reduce costs to consumers2 and insurers and reduce stress on the overall economy.3 After all, the least expensive medical challenge is the one that never happens or the one that is treated before it becomes catastrophic.

In 2024, our goal is to impress upon people that the time to prepare is now. Think about it - would you wait for a hurricane to happen before weatherproofing your house? Of course not. Instead, you would install storm shutters, secure loose items in the yard and, yes, purchase insurance that will cover your property in the event of significant damage. We should do the same with our health care.

The American Cancer Society recently released its 2024 statistics. Some of the news is good. Death rates from cancer are declining due to, you guessed it, early detection and improvements in treatment protocols.

We urge people, regardless of life stage, to review the cancer warning signals, none of which would mean you have cancer, but could serve as incentive to see your doctor.4 Young people should develop good health habits, particularly as advancements like telemedicine have made it easier than ever to have a routine examination.

Of course, we believe Aflac is the preferred choice for individuals seeking the financial protection provided by supplemental health insurance, but our concern goes much deeper than that. We simply don't want families to go through what my friend's wife endured, when it could be avoided.

Dan Amos is Chairman, CEO and President of Aflac Incorporated. In his 34th year, he is the 5th longest-serving CEO in the Fortune 500.

1 Sparks, Hannah. "Millions of Americans can't afford doctor visits during pandemic: study." March 31, 2001. https://nypost.com/2021/03/31/46m-americans-avoided-doctor-during-pandemic-due-to-costs/, accessed on Feb. 5, 2024.

2 World Health Organization, "Promoting cancer early diagnosis." Accessed on Jan. 29, 2024. https://www.who.int/activities/promoting-cancer-early-diagnosis.

3 Fendrick, Mark, M.D. "Cancer screenings have saved the U.S. at least $6.5 trillion, study estimates." University of Michigan. Aug. 17, 2023. https://thrive.kaiserpermanente.org/care-near-you/northern-california/santarosa/wp-content/uploads/sites/15/2015/10/Cancer-Warning-Signals_tcm28-808438.pdf, Accessed on Feb. 5, 2024.

4 Kaiser Permanente, "Cancer Warning Signals." Accessed on Jan. 29, 2024. https://thrive.kaiserpermanente.org/care-near-you/northern-california/santarosa/wp-content/uploads/sites/15/2015/10/Cancer-Warning-Signals_tcm28-808438.pdf.

Content within this article is intended to provide general information about an evolving topic and does not constitute legal or financial advice regarding any specific situation. This information is not intended to portray any specific details of Aflac supplemental insurance policies. For complete details, including availability and costs of Aflac insurance, please contact your local Aflac agent. Aflac supplemental coverage is underwritten by American Family Life Assurance Company of Columbus. In New York, Aflac supplemental coverage is underwritten by American Family Life Assurance Company of New York.

Aflac | WWHQ | 1932 Wynnton Road | Columbus, GA 31999

Z2400069

View additional multimedia and more ESG storytelling from Aflac Incorporated on 3blmedia.com.

Contact Info:
Spokesperson: Aflac Incorporated
Website: https://www.3blmedia.com/profiles/aflac-incorporated
Email: info@3blmedia.com

SOURCE: Aflac Incorporated



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.